Cargando…
A functional CRISPR/Cas9 screen identifies kinases that modulate FGFR inhibitor response in gastric cancer
Some gastric cancers have FGFR2 amplifications, making them sensitive to FGFR inhibitors. However, cancer cells inevitably develop resistance despite initial response. The underlying resistance mechanism to FGFR inhibition is unclear. In this study, we applied a kinome-wide CRISPR/Cas9 screen to sys...
Autores principales: | Chen, Jiamin, Bell, John, Lau, Billy T., Whittaker, Tyler, Stapleton, Darren, Ji, Hanlee P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510732/ https://www.ncbi.nlm.nih.gov/pubmed/31076567 http://dx.doi.org/10.1038/s41389-019-0145-z |
Ejemplares similares
-
CRISPR–Cas9-targeted fragmentation and selective sequencing enable massively parallel microsatellite analysis
por: Shin, GiWon, et al.
Publicado: (2017) -
Abstract 21: Identifying New Mutations Of Fgfr1a After CRISPR/Cas9 Genome Editing
por: Kelsey, Lauren, et al.
Publicado: (2017) -
Single-cell transcriptome analysis identifies distinct cell types and niche signaling in a primary gastric organoid model
por: Chen, Jiamin, et al.
Publicado: (2019) -
CRISPR/Cas9 screening using unique molecular identifiers
por: Schmierer, Bernhard, et al.
Publicado: (2017) -
CRISPR/Cas9‐enhanced ssDNA recombineering for Pseudomonas putida
por: Aparicio, Tomás, et al.
Publicado: (2019)